Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Haploflow: Tracing the disease back to its Origin

Mynvax raises $4.2M to develop ‘thermostable’ Covid-vaccine

Role of lysosomes and α-synuclein fibrils in protein misfolding

Haploflow: Tracing the disease back to its Origin
  • BiotechToday
  • World

Haploflow: Tracing the disease back to its Origin

BioTech Today July 22, 2021July 21, 2021

Agrima Bhatt, Rajasthan University

In the last few decades, humankind has gone through major healthcare upheavals causing a large amount of death and destruction. Epidemics, pandemics have come, some have passed with time but some have evolved to stay. And as we continue forward, scientists are already predicting the next pandemic to come soon. In the history of time, however, viral infections have continued to prevail, whether we talk about the present coronavirus or the emergence of H1N1 in 1918. 

Medical research keeps on pondering the many questions that virus holds, researchers have grabbed onto very limited knowledge of it and continued to explore their physiology. This article discusses the details on viral pathogens, genome assembly of the viral strain, among other issues relevant to the same.

What is a Viral Pathogen and its Strains?

Pathogens refer to the organisms responsible for causing a disease. Different pathogens cause different diseases in the host organism. A viral pathogen can be termed as a substance that is small in size as compared to bacteria. Viral pathogens are much more infectious as they invade the host cells and reproduce in number through the process of replication. They use the host organism’s protein machinery for a continuous replication process. 

What is interesting to know is that all viruses possess the ability to mutate and co-infect. The process of its mutation depends on the type of genome as a virus containing RNA can mutate faster. Co-infection strengthens the possibility of the presence of multiple related viral strains within the host. If the genomes of these viral strains could be reconstructed, we can find out the repercussions of their infections. This exploration will also increase our very limited knowledge of these viruses and their strains.

What is Haploflow?

Haploflow is one such de novo genome assembly software developed by German scientists. It uses a novel flow algorithm to reconstruct viral strain genomes. The traditional genome assembly can be a bit challenging, however, Haploflow uses the fast algorithms of the metagenome assemblers. It captures variation between different strains and combines those variants together that are not occurring twice.

After experimentation, Haploflow was found to be correct in most metrics as compared to the results of 12 other assemblers.  Haploflow was able to assemble the three genomes entirely with few corrections in an HIV data set. It scored a total of 9.66 out of 10 in comparison with PredictHaplo and PEHaplo.

Applications and Future Use:

Haploflow was able to perform reconstruction on SARS-CoV-2 samples. It showed a high duplication ratio in its genome assembly when assessed with QUAST.  These technologies can be a key to know more about the genetic epidemiology of viruses and genome-based viral phenotyping. This allows people to trace the disease back to its viral strains to avoid a future pandemic.

This reconstruction of genomes allows the software to perform the most complex computational biology tasks. As we move to the future, and research and development continue to soar high, scientists are eager to see if one day maybe we can perform de novo genome assembly on humans as well.

Also read: Are probiotics and prebiotics safe during pregnancy & lactation?

References:

  1. Fritz, A., Bremges, A., Deng, Z.-L., Lesker, T. R., Götting, J., Ganzenmueller, T., Sczyrba, A., Dilthey, A., Klawonn, F., & McHardy, A. C. (2021). Haploflow: strain- resolved de novo assembly of viral genomes. Genome Biology, 22(1). https://doi.org/10.1186/s13059-021-02426-8.
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Author’s info:

Agrima Bhatt is an undergraduate student studying BSc. Biotechnology in Jaipur, Rajasthan. She is a science and research enthusiast who also loves to write articles and short snippets.

Some of her published articles at BioXone are:

  1. https://bioxone.in/news/worldnews/molecular-mechanisms-underlying-virescent-mutation-in-cotton/
  2. https://bioxone.in/news/worldnews/multi-angle-projection-microscope-a-novel-imaging-technique/
  3. https://bioxone.in/news/worldnews/scientists-develop-novel-cholera-vaccine-from-rice-grains/
  4. https://bioxone.in/news/worldnews/ai-predicts-the-relation-between-viruses-and-mammals/

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged co-infection de novo epidemic genome Haploflow host pandemic pathogen strains viral infection

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Role of lysosomes and α-synuclein fibrils in protein misfolding

BioTech Today July 23, 2021

Husna, Amity University Kolkata α-synuclein (α-syn) are small cytoplasmic proteins found in the brain and are localized to presynaptic terminals which inhibit the release of neurotransmitters. α-synuclein (α-syn) aggregates or their inclusions accumulate in specific regions of the brain; this abnormal accumulation is a hallmark of synucleinopathies (a group of neurodegenerative diseases) like Parkinson’s disease […]

α-synuclein

Related Post

  • BiotechToday
  • World

Formin: The mastermind for fighting symbionts in legumes!!!

BioTech Today May 11, 2021May 11, 2021

Camelia Bhattacharyya, Amity University Kolkata Nitrogen fixation is a term we often use while mentioning legumes. Legumes are plants that contain Rhizobium bacteria inside their root nodules. These bacteria help in converting nitrogen into nitrites and nitrates which are further used by the plant. This entire process is how nitrogen fixation takes place. This process […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

A relaxin based nanoparticle treats liver fibrosis

bioxone January 29, 2021January 29, 2021

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA Liver fibrosis is one of the leading causes of morbidity and mortality among human beings. The unavailability of proper antifibrotic therapy makes the disease more deadly and the patients more vulnerable. RLX ( peptide hormone human relaxin-2), acting through a G protein-coupled receptor relaxin peptide receptor 1 (RXFP1), promotes tissue […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

2-DG: an anti-COVID drug approved by the DCGI

bioxone May 13, 2021May 13, 2021

Camelia Bhattacharyya, Amity University Kolkata As rightfully pointed out by Lois McMaster Bujold, “The dead cannot cry out for justice. The living must do so for them.” Philosophically looking into the sentence, this is exactly what the present situation of the COVID requires. There are several deaths of loved ones all around in India and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy